Pacific Shuanglin Bio-pharmacy Co., LTD (SHE: 000403)

Pacific Shuanglin Bio-pharmacy Co., LTD Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Jan 1, 2021	Jan 1, 2020
Cash & Equivalents	754.19	1,429	1,001	885.67	102.83	110.94
Trading Asset Securities	1,000	423.34	422.44	234.21	-	-
Cash & Short-Term Investments	1,754	1,853	1,423	1,120	102.83	110.94
Cash Growth	21.53%	30.17%	27.09%	989.09%	-7.32%	-28.32%
Accounts Receivable	592.31	619.51	891.08	581.12	314.17	241.75
Other Receivables	8.37	15.6	49.71	12.83	5.75	16.33
Receivables	600.69	635.11	940.79	593.95	319.93	258.08
Inventory	1,139	909.37	623.69	738.97	441.76	404.65
Prepaid Expenses	-	0.3	0.14	0	1.76	0.03
Other Current Assets	48.05	28.6	59.12	16.53	6.44	5.22
Total Current Assets	3,542	3,426	3,047	2,469	872.71	778.93
Property, Plant & Equipment	1,862	1,554	1,297	1,103	410.91	388.09
Goodwill	2,615	2,615	2,615	2,615	-	-
Other Intangible Assets	203.91	212.59	192.52	200.05	65.46	54.22
Long-Term Deferred Tax Assets	41.04	49.04	49.09	27.35	11.75	10.68
Long-Term Deferred Charges	101.55	79.47	89.7	67.42	36.04	37.06
Other Long-Term Assets	687.51	694.87	692.81	605.82	282.85	2.67
Total Assets	9,053	8,630	7,982	7,088	1,680	1,272
Accounts Payable	178.49	154.35	158.37	158.7	38.32	31.77
Accrued Expenses	31.49	373.56	373.49	239.21	171.81	259.6
Short-Term Debt	265.7	250.57	275.1	113.52	332.41	110
Current Portion of Long-Term Debt	37.22	21.22	8.63	-	-	-
Current Portion of Leases	-	6.67	7.14	7.05	5.28	-
Current Income Taxes Payable	54.98	39.72	43.08	24.22	18.31	8.9
Current Unearned Revenue	9.68	10.76	25.91	11.54	5.2	7.26
Other Current Liabilities	293.89	65.34	67.58	88.04	74.19	22.53
Total Current Liabilities	871.46	922.19	959.31	642.29	645.51	440.06
Long-Term Debt	271.23	196.08	52.89	-	20.02	-
Long-Term Leases	22.03	21.48	29.59	20.89	22.33	-
Long-Term Unearned Revenue	33.48	35.6	40.08	49.24	15.95	20.02
Long-Term Deferred Tax Liabilities	21.19	24.26	30.33	36.52	-	-
Other Long-Term Liabilities	9	9	9	11.14	9	9.96
Total Liabilities	1,228	1,209	1,121	760.07	712.82	470.04
Common Stock	733.04	733	732.39	732.92	492.43	272.58
Additional Paid-In Capital	4,796	4,793	4,779	4,779	52.56	116.44
Retained Earnings	2,342	1,946	1,392	846.23	455.3	411.21
Treasury Stock	-40.11	-43.17	-36.22	-32	-34.98	-
Comprehensive Income & Other	0.04	0.05	0.04	-0	-	-
Total Common Equity	7,832	7,429	6,868	6,326	965.32	800.22
Minority Interest	-6.88	-6.79	-6.4	2.07	1.59	1.38
Shareholders' Equity	7,825	7,422	6,861	6,328	966.91	801.6
Total Liabilities & Equity	9,053	8,630	7,982	7,088	1,680	1,272
Total Debt	596.18	496.02	373.36	141.46	380.04	110
Net Cash (Debt)	1,158	1,357	1,050	978.42	-277.21	0.94
Net Cash Growth	20.48%	29.22%	7.30%	-	-	-
Net Cash Per Share	1.59	1.86	1.44	1.38	-0.57	0.00
Filing Date Shares Outstanding	731.15	730.82	732.39	732.92	732.04	489.22
Total Common Shares Outstanding	731.15	731.03	732.39	732.92	492.43	489.22
Working Capital	2,671	2,504	2,088	1,827	227.2	338.87
Book Value Per Share	10.71	10.16	9.38	8.63	1.96	1.64
Tangible Book Value	5,013	4,601	4,060	3,511	899.86	746
Tangible Book Value Per Share	6.86	6.29	5.54	4.79	1.83	1.52
Buildings	-	833.6	701.14	583.25	261.01	265.54
Machinery	-	961.1	920.37	729.45	324.38	358.4
Construction In Progress	-	582.7	385.73	334.38	32.73	8.47

Source: S&P Capital IQ. Standard template. Financial Sources.